News Article

Constellation Healthcare Technologies – appointment as NED

Constellation Healthcare Technologies, Inc.

(“Constellation” or “the Company”)

Directorate Changes

Constellation Healthcare Technologies, Inc., the US based healthcare services and technology Company is pleased to announce the appointment of Sir Rodney Aldridge as a Non-Executive Director, effective immediately.

Sir Rodney Aldridge is the Founder of the Capita Group and led the Company from a start-up in 1984 to his retirement in 2006. During this time the Group grew to become a FTSE 100 company and a market leader in the provision of support and professional services to the government and private sector in the UK.

Sir Rodney was awarded an OBE in the 1994 New Year Honours list and was given the freedom of the City of London in 1996. In 2006 he was elected fellow of the Royal Society of the Arts and in 2012 he received a knighthood.

Since Constellation’s IPO in December 2014 Sir Rodney has been the beneficial owner of 740,741 common shares of $0.0001 each in the capital of the Company representing 1.33% of the issued share capital of the Company.

Commenting on Sir Rodney’s appointment Paul Parmar, CEO of Constellation, said: “There is no one better suited to help advise the Company in its current growth stage than Sir Rodney. As founder and CEO of Capita, he understands how to build an outsource service business organically and through acquisition. His guidance to the Board and the business as a whole will be invaluable as he has a proven track record of buying and building businesses and successfully integrating them. Sir Rodney understands our business and his years of experience will be a real asset to the Board and the Company going forward.”

Sir Rodney said, “I am very excited about joining the Board of Constellation.  The business model offers the opportunity to build a substantial position in a very large, diverse and attractive market through acquiring companies, consolidating the services provided and then growing organically. This is a model that I have a lot of experience of operating successfully with Capita. I feel that Constellation has the platform from which to build a highly scalable, profitable business and I look forward to playing my part in delivering that goal.”

Enquiries:

Constellation Healthcare TechnologiesPaul Parmar, Chief Executive Officer c/o Redleaf Communications+44 (0)20 7382 4730
finnCap – Nominated Adviser and Joint BrokerJulian Blunt / Scott Mathieson +44 (0)20 7220 0500
Stifel – Joint BrokerJonathan Senior / Giles Balleny / Ben Maddison +44 (0)20 7710 7600
 Redleaf Communications – PR adviserCharlie Geller/Harriet Lynch  +44 (0)20 7382 4730constellation@redleafpr.com

The following information in relation to Sir Rodney Aldridge is disclosed in accordance with Schedule 2(g) of the AIM Rules for Companies.

Full name: Rodney Malcolm Aldridge

Age: 67

Shares held: 740,741 common shares of $0.0001 each representing 1.33% of the issued share capital of the Company

Directorships/partnerships held in the last five years:

Current Past
The Lowry Centre Development Company Limited Vinspired
The Lowry Centre Limited User Voice
The Lowry Centre Trust Essentially Dance Limited
Equiniti Group Limited Essentially Dancing Limited
Equiniti X2 Enterprises Limited Isle of Portland Aldridge Community Academy Trust
Equiniti Enterprises Limited Parker Founders LLP
Equiniti Cleanco Limited Parker Founder Capital LLP
Portslade Aldridge Community Academy Trust Parker RMAI Limited
Kensington Aldridge Academy Parker Capital Limited
RMAI Limited Parker Capital Acquisitions Limited
Creative Industries UTC Aldridge North West Education Trust
Aldridge North West Education Trust Brighton Aldridge Community Academy
Aldridge Capital Limited Acorn Care 1 Limited
Aldridge Investment Limited
Aldridge Centre for Entrepreneurship
Fairmile Homes One Limited
National College for Digital Skills Limited
Cornerstone Property Assets Limited

 

There are no other matters which are required to be announced for Sir Rodney Aldridge pursuant to Schedule 2(g) of the AIM Rules for Companies.

Image courtesy of Constellation Healthcare Technologies